BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37224601)

  • 1. Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity.
    Ishii T; Kobayakawa T; Matsuda K; Tsuji K; Ohashi N; Nakahata S; Noborio A; Yoshimura K; Mitsuya H; Maeda K; Tamamura H
    Eur J Med Chem; 2023 Aug; 256():115449. PubMed ID: 37224601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing Agents.
    Ishii T; Kobayakawa T; Matsuda K; Nigorikawa K; Bolah P; Noborio A; Tsuji K; Ohashi N; Yoshimura K; Nomura W; Mitsuya H; Maeda K; Tamamura H
    ACS Infect Dis; 2024 Jun; 10(6):2250-2261. PubMed ID: 38771724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC Activators.
    Matsuda K; Kobayakawa T; Kariya R; Tsuchiya K; Ryu S; Tsuji K; Ishii T; Gatanaga H; Yoshimura K; Okada S; Hamada A; Mitsuya H; Tamamura H; Maeda K
    Front Microbiol; 2021; 12():636276. PubMed ID: 33815322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversal.
    Matsuda K; Kobayakawa T; Tsuchiya K; Hattori SI; Nomura W; Gatanaga H; Yoshimura K; Oka S; Endo Y; Tamamura H; Mitsuya H; Maeda K
    J Biol Chem; 2019 Jan; 294(1):116-129. PubMed ID: 30413535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
    Abner E; Stoszko M; Zeng L; Chen HC; Izquierdo-Bouldstridge A; Konuma T; Zorita E; Fanunza E; Zhang Q; Mahmoudi T; Zhou MM; Filion GJ; Jordan A
    J Virol; 2018 May; 92(10):. PubMed ID: 29343578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors.
    Painter MM; Zaikos TD; Collins KL
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29021396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Combinations of Protein Kinase C Activators and Histone Deacetylase Inhibitors That Potently Reactivate Latent HIV.
    Curreli F; Ahmed S; Victor SMB; Debnath AK
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32503121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA.
    Taylor JP; Armitage LH; Aldridge DL; Cash MN; Wallet MA
    Biol Open; 2020 Dec; 9(12):. PubMed ID: 33234703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation.
    Larragoite ET; Nell RA; Martins LJ; Barrows LR; Planelles V; Spivak AM
    Biochem Pharmacol; 2022 Jan; 195():114844. PubMed ID: 34801521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Gene Modulation of HIV-Infected CD4 T Cells in Response to Serial Treatment with the Histone Deacetylase Inhibitor Vorinostat.
    Maxwell JW; Falcinelli SD; Nefedov A; Dorfmeier C; Wu G; Dewey M; Webber AL; Archin NM; Margolis DM; Hazuda DJ; Barnard RJO; Howell BJ
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Novel PKC Activator 10-Methyl-Aplog-1 Combined with JQ1 Induced Strong and Synergistic HIV Reactivation with Tolerable Global T Cell Activation.
    Washizaki A; Murata M; Seki Y; Kikumori M; Tang Y; Tan W; Wardani NP; Irie K; Akari H
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.
    De la Torre-Tarazona HE; Jiménez R; Bueno P; Camarero S; Román L; Fernández-García JL; Beltrán M; Nothias LF; Cachet X; Paolini J; Litaudon M; Alcami J; Bedoya LM
    Biochem Pharmacol; 2020 Jul; 177():113937. PubMed ID: 32224142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir.
    Dai W; Wu F; McMyn N; Song B; Walker-Sperling VE; Varriale J; Zhang H; Barouch DH; Siliciano JD; Li W; Siliciano RF
    Sci Transl Med; 2022 Oct; 14(667):eabh3351. PubMed ID: 36260688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
    Banga R; Procopio FA; Cavassini M; Perreau M
    J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents.
    Gupta V; Dixit NM
    PLoS Comput Biol; 2018 Feb; 14(2):e1006004. PubMed ID: 29451894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of small molecule HIV-1 latency reversing agents identified in low- and high-throughput small molecule screens.
    Hashemi P; Sadowski I
    Med Res Rev; 2020 May; 40(3):881-908. PubMed ID: 31608481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
    Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oocyte activation and latent HIV-1 reactivation: AMPK as a common mechanism of action linking the beginnings of life and the potential eradication of HIV-1.
    Finley J
    Med Hypotheses; 2016 Aug; 93():34-47. PubMed ID: 27372854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
    Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
    Rochat MA; Schlaepfer E; Speck RF
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.